Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion
Annunziato, L.; Quattrone, A.; Schettini, G.; Di Renzo, G.
Advances in Biochemical Psychopharmacology 24: 379-385
1980
ISSN/ISBN: 0065-2229 PMID: 6105788 Document Number: 166009
Document emailed within 1 workday
Related Documents
Grandison, L. 1981: Anterior pituitary GABA receptors and their regulation of prolactin secretion Advances in Biochemical Psychopharmacology 26: 219-227Wolfe, S.E.; Brostrom, C.O.; Brostrom, M.A. 1986: Mechanisms of action of inhibitors of prolactin secretion in GH3 pituitary cells. I. Ca2+-dependent inhibition of amino acid incorporation Molecular Pharmacology 29(4): 411-419
Biggio, G.; Casu, M.; Klimek, V.; Gessa, G.L. 1980: Dopamine synthesis: tolerance to haloperidol and supersensitivity to apomorphine depend on presynaptic receptors Advances in Biochemical Psychopharmacology 24: 17-22
Gnegy, M.; Uzunov, P.; Costa, E. 1977: Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors Journal of Pharmacology and Experimental Therapeutics 202(3): 558-564
Frawley, L.S.; Neill, J.D. 1984: Brief decreases in dopamine result in surges of prolactin secretion in monkeys American Journal of Physiology 247(6 Pt 1): E778-E780
Sharpe R.M. 1979: Modulation of prolactin luteinizing hormone and follicle stimulating hormone secretion by luteinizing hormone releasing hormone and bromocriptine cb 154 in the hypophysectomized pituitary grafted male rat and its effect on testicular luteinizing hormone receptors and testosterone output Biology of Reproduction 21(1): 141-148
Jaquet, P.; Gunz, G.; Saveanu, A.; Barlier, A.; Dufour, H.; Taylor, J.; Dong, J.; Kim, S.; Moreau, J.P.; Culler, M.D. 2005: BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide Journal of Endocrinological Investigation 28(11 Suppl International): 21-27
Valueva, G.V.; Iakovlev, A.A. 1987: Role of the renin-angiotensin system and prolactin in dopamine-induced secretion of aldosterone Vestnik Akademii Meditsinskikh Nauk SSSR 12: 61-65
Balabolkin, M.I.; Gerasimov, G.A.; Gubernatorov, E.E.; Kizyma, L.A. 1991: Role of enzymes of dopamine metabolism in the regulation of prolactin and thyrotropin secretion in hyperprolactinemia Problemy Endokrinologii 37(3): 26-28
Jeske, W.; Stopińska, U. 1981: The effect of nomifensine on prolactin secretion in patients with suspected pituitary microadenoma Endokrynologia Polska 32(1): 17-24
Marek, J.; Srámková, J. 1977: Stimulation tests of prolactin secretion in the diagnosis of hypothalamic and pituitary diseases Vnitrni Lekarstvi 23(10): 976-987
Akikawa, K. 1985: Studies on mechanisms of prolactin synthesis and secretion using perfusion system of rat pituitary cells Hokkaido Journal of Medical Science 60(3): 404-414
Bowden, C.R.; Voina, S.J.; Woestenborghs, R.; De Coster, R.; Heykants, J. 1992: Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro Journal of Pharmacology and Experimental Therapeutics 262(2): 699-706
Jones, C.D.; Bartee, J.A.; Leite-Browning, M.L.; Blackshear, M.A. 2007: Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved? Cellular and Molecular Biology 53(4): 15-22
Lamberts, S.W.; Klijn, J.G.; Kwa, G.H.; Birkenhäger, J.C. 1979: The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours Acta Endocrinologica 90(2): 198-210
Maeda, T.; Sawada, K.; Itoh, Y.; Moriwaki, K.; Mori, H. 1991: Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist Laboratory Investigation; a Journal of Technical Methods and Pathology 65(6): 679-687
Poli, M.; Caviezel, F.; Girardi, A.M.; Bosi, E.; Pozza, G. 1980: Inhibition of sulpiride-induced prolactin secretion by dihydroergocristine in man Advances in Biochemical Psychopharmacology 24: 445-449
Franks, S.; Nabarro, J.D. 1978: Prolactin secretion in patients with chromophobe adenomas of the pituitary: incidence and presentation of hyperprolactinaemia: results of surgical treatment Annals of Clinical Research 10(3): 157-163
Ferrari, C.; Romussi, M.; Benco, R.; Rampini, P.; Mailland, F. 1983: Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions Acta Endocrinologica 103(1): 1-6
Welsch, C.W.; Brown, C.K.; Goodrich-Smith, M.; Van, J.; Denenberg, B.; Anderson, T.M.; Brooks, C.L. 1979: Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion Journal of the National Cancer Institute 63(5): 1211-1214